This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rubin, M. A. Articles by Pirog, E. C. Search for Related Content PubMed PubMed Citation Articles by Rubin, M. A. Articles by Pirog, E. C.

(American Journal of Pathology. 2001;159:1211-1218.)
© 2001 American Society for Investigative Pathology

Short Communications

Detection and Typing of Human Papillomavirus DNA in Penile Carcinoma

Evidence for Multiple Independent Pathways of Penile Carcinogenesis

Mark A. Rubin^*, Bernard Kleter, Ming Zhou^*, Gustavo Ayala, Antonio L. Cubilla, Wim G. V. Quint^¶ and Edyta C. Pirog^||

From the Department of Pathology,^*
University of Michigan, Ann Arbor, Michigan; the Delft Diagnostic Laboratory,
Delft, The Netherlands; the Department of Pathology,
Baylor College of Medicine, Houston, Texas; the Department of Pathology,
Universidad Nacional de Asuncion, Asuncion, Paraguay; the Academic Medical Center,^¶
Amsterdam, The Netherlands; and the Department of Pathology,^||
Cornell University, New York, New York

To clarify the role of human papillomavirus (HPV) in penile cancer we evaluated the prevalence of HPV DNA in different histological subtypes of penile carcinoma, dysplasia, and condyloma using a novel, sensitive SPF10 HPV polymerase chain reaction assay and a novel genotyping line probe assay, allowing simultaneous identification of 25 different HPV types. Formalin-fixed, paraffin-embedded tissue samples were collected from the United States and Paraguay. HPV DNA was detected in 42% cases of penile carcinoma, 90% cases of dysplasia, and 100% cases of condyloma. There were significant differences in HPV prevalence in different histological cancer subtypes. Although keratinizing squamous cell carcinoma and verrucous carcinoma were positive for HPV DNA in only 34.9 and 33.3% of cases, respectively, HPV DNA was detected in 80% of basaloid and 100% of warty tumor subtypes. There was no significant difference in HPV prevalence between cases from Paraguay and the United States. In conclusion, the overall prevalence of HPV DNA in penile carcinoma (42%) is lower than that in cervical carcinoma (100%) and similar to vulvar carcinoma (50%). In addition, specific histological subtypes of penile cancer—basaloid and warty—are consistently associated with HPV, however, only a subset of keratinizing and verrucous penile carcinomas is positive for HPV DNA, and thus these two tumor groups seem to develop along different pathogenetic pathways.

This article has been cited by other articles:

				D. Green and D. Catlow Immunisation against human papilloma virus in a primary care trust: a report on the first three months of the national campaign Journal of Infection Prevention, May 1, 2009; 10(3): 112 - 115. [Abstract] [PDF]

				E. Cazap A Global Vision from Scientific Knowledge to Reality ASCO Educational Book, January 1, 2009; 2009(1): 56 - 60. [Abstract] [Full Text] [PDF]

				F. Ogunmodede, S. H. Yale, B. Krawisz, G. C. Tyler, and A. C. Evans Human Papillomavirus Infections in Primary Care Clin. Med. Res., December 1, 2007; 5(4): 210 - 217. [Abstract] [Full Text] [PDF]

				D. A.M. Heideman, T. Waterboer, M. Pawlita, P. Delis-van Diemen, I. Nindl, J. A. Leijte, J. M.G. Bonfrer, S. Horenblas, C. J.L.M. Meijer, and P. J.F. Snijders Human Papillomavirus-16 Is the Predominant Type Etiologically Involved in Penile Squamous Cell Carcinoma J. Clin. Oncol., October 10, 2007; 25(29): 4550 - 4556. [Abstract] [Full Text] [PDF]

				M. T. Goodman, B. Y. Hernandez, and Y. B. Shvetsov Demographic and Pathologic Differences in the Incidence of Invasive Penile Cancer in the United States, 1995-2003 Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1833 - 1839. [Abstract] [Full Text] [PDF]

				D. Saslow, P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, D. M. Harper, W. Kinney, A.-B. Moscicki, et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors CA Cancer J Clin, January 1, 2007; 57(1): 7 - 28. [Abstract] [Full Text] [PDF]

				S. Saeed, C. A. Keehn, F. K Khalil, and M. B. Morgan Immunohistochemical Expression of Bax and Bcl-2 in Penile Carcinoma Ann. Clin. Lab. Sci., January 1, 2005; 35(1): 91 - 96. [Abstract] [Full Text] [PDF]

				A. L. Cubilla, E. F. Velazquez, and R. H. Young Epithelial Lesions Associated with Invasive Penile Squamous Cell Carcinoma: A Pathologic Study of 288 Cases International Journal of Surgical Pathology, October 1, 2004; 12(4): 351 - 364. [Abstract] [PDF]

				K. Middleton, W. Peh, S. Southern, H. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, et al. Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers J. Virol., October 1, 2003; 77(19): 10186 - 10201. [Abstract] [Full Text] [PDF]

				M. Schiffman and S. K. Kjaer Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 14 - 19. [Abstract] [Full Text] [PDF]

				M. L. Gillison and K. V. Shah Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 57 - 65. [Abstract] [Full Text] [PDF]

				A. Ouban, J. Dellis, R. Salup, and M. Morgan Immunohistochemical Expression of Mdm2 and p53 in Penile Verrucous Carcinoma Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 101 - 106. [Abstract] [Full Text] [PDF]